ACE2 and obesity disorder: Overall, elevated ACE2 levels in the liver of patients with obesity and related metabolic disturbances, together with exacerbated pro‐inflammatory responses as a consequence of hepatic steatosis, may well explain the poorer prognosis of these patients upon SARS‐CoV‐2 infection (Figure 1).